Ospedale Ruber Internacional
| Turchia | Austria | Spagna | |
| Resezione epatica | da $11,700 | da $35,000 | da $35,000 |
| Chemoembolizzazione del fegato | da $7,500 | da $16,000 | da $12,000 |
| Asportazione del tumore al fegato | da $10,800 | da $40,000 | da $35,000 |
| Ablazione con radiofrequenza del fegato | da $3,500 | da $12,000 | da $8,500 |
| Chemioterapia per il cancro al fegato | da $1,800 | - | da $570 |
Il Dr. Jaume Capdevila ha effettuato oltre 1.100 trattamenti per pazienti oncologici, specializzandosi in casi di cancro avanzato presso il Centro Médico Teknon.
La dottoressa è un chirurgo oncologico specializzato in carcinosi peritoneale e fa parte del Gruppo Chirurgico di Carcinosi dell'Istituto Oncologico Teknon dal 2019. Ha completato la sua specializzazione al Washington Hospital Center sotto la guida del Prof. Paul Sugarbaker e possiede la certificazione dell'American Board of Surgery.<\/p>
È membro di diverse società prestigiose, tra cui l'American College of Surgeons e la Society of Surgical Oncology. I suoi ruoli accademici hanno incluso il Direttore della Ricerca presso l'Inova Fairfax Hospital e posizioni di Professore Associato presso la Virginia Commonwealth University e la Georgetown University.<\/p>
Il dottore è un educatore e ricercatore affermato nel campo dell'oncologia, con un'ampia esperienza di insegnamento presso USP CEU. Il dottore ha insegnato una vasta gamma di materie, tra cui Patologia Medica Generale, Oncologia Orale e Maxillo-facciale e Bioetica. Come tutor per studenti di medicina e rotanti esterni, il dottore ha contribuito significativamente alla formazione dei futuri professionisti della salute.<\/p>
Inoltre, il dottore ricopre la posizione di Direttore della ricerca post-laurea in oncologia clinica e applicata presso HM CIOCC USP CEU ed è responsabile delle pratiche di master post-laurea. Il dottore ha anche completato corsi avanzati presso il MD Anderson Cancer Center.<\/p>
Il medico è un oncologo pediatrico con 37 anni di esperienza, specializzato nel trattamento dei disturbi del sangue e nell'esecuzione di procedure come i trapianti di midollo osseo e la terapia ablativa. Attualmente, il medico è Capo dell'Emato-Oncologia Pediatrica presso l'Ospedale Universitario Quironsalud Madrid.<\/p>
Con un prolifico curriculum accademico, il medico ha curato 14 libri, contribuito a 75 capitoli di libri e presentato a oltre 200 conferenze. Il medico è membro di diverse associazioni professionali, tra cui l'Associazione Spagnola di Ematologia Pediatrica e l'Associazione Spagnola di Oncologia Pediatrica.<\/p>
Il medico tratta un'ampia gamma di condizioni, tra cui leucemia, linfoma, mieloma multiplo e vari disturbi ematologici e autoimmuni.<\/p>
Spanish centers offer advanced surgical techniques for unresectable liver metastases including ALPPS, two-stage hepatectomies, and histotripsy. These protocols focus on rapid liver regeneration and non-thermal tumor destruction. Specialist teams in Madrid and Barcelona utilize intraoperative navigation to preserve healthy parenchymal tissue during resection.
Bookimed Expert Insight: Spain is a global leader in high-volume hepatobiliary care, with centers like Centro Médico Teknon performing 23,500 operations annually. Data shows that Spanish specialists like Dr. Lana Bijelic often combine resection with intraoperative ablation. This allows treatment of multiple nodules that would typically be deemed unresectable elsewhere. Choosing centers with multidisciplinary liver boards ensures access to these combined-modality protocols.
Patient Consensus: Patients often find that seeking a second opinion at high-volume Spanish centers is vital. They note that what one hospital labels unresectable may be eligible for staged surgery or ablation-assisted resection.
Spanish medical centers offer non-surgical local therapies including percutaneous ablation, transarterial procedures, and targeted radiation. These treatments destroy liver tumors without major surgery. Options like radiofrequency ablation (RFA) and chemoembolization are available at JCI-accredited facilities in Madrid and Barcelona.
Bookimed Expert Insight: Spanish oncology centers like Centro Médico Teknon and Hospital Ruber Internacional stand out due to their high patient volumes and JCI accreditation. Data shows these facilities manage over 10,000 cases annually. This volume correlates with deep expertise in managing complex oligometastatic liver disease through multidisciplinary tumor boards.
Patient Consensus: Patients note it's important to confirm if a center has on-site interventional radiology. Many emphasize requesting a multidisciplinary review to choose between ablation and SIRT.
Patients can access pioneering clinical trials for liver metastases in Spain. The country is a leading European oncology research hub. Specialized trials focus on molecular profiling and liver-directed therapies. Leading centers like Quironsalud Madrid and Hospital Universitario HM Sanchinarro authorize numerous clinical studies yearly.
Bookimed Expert Insight: Spain’s clinical trial landscape allows for unique opportunities where treatment costs might be fully covered for eligible participants. At Quironsalud Madrid, our data shows patients can potentially access therapy for free if they meet strict study criteria. This is particularly valuable for liver metastases where traditional treatment costs can rise quickly.
Patient Consensus: Patients note that having a doctor who understands the trial network is vital for successful entry. They emphasize that specific tumor markers often determine if you qualify for the most advanced research pathways.
Spain hosts several JCI-accredited facilities specializing in liver metastasis, including Centro Médico Teknon in Barcelona and Clinica Universidad de Navarra in Pamplona. These centers utilize multidisciplinary teams to provide liver resection, radiofrequency ablation, and chemoembolization. Leading specialists like Dr. Jaume Capdevila coordinate complex oncology care.
Bookimed Expert Insight: Patient volume indicates that high-capacity centers like Hospital HM Nou Delfos treat 400,000 patients annually. This massive scale often correlates with faster diagnostic turnaround for complex cases. Large multi-center groups like HM Hospitales ensure specialized oncology teams are available across their 7 integrated facilities.
Patient Consensus: Patients emphasize that multidisciplinary reviews are vital. It is common to travel to Madrid or Barcelona for evaluation at high-volume liver units.
Spanish oncologists stage liver metastases by combining high-resolution triple-phase CT or contrast-enhanced MRI with mandatory genomic profiling. They categorize cases into resectable, borderline, or unresectable phenotypes. Treatment plans are designed by multidisciplinary tumor boards to ensure personalized, multimodal care for every patient.
Bookimed Expert Insight: Spanish centers like Clinica Universidad de Navarra and Centro Médico Teknon provide a distinct advantage through high patient volumes. Clinica Universidad de Navarra treats over 140,000 patients from 70 countries annually. This vast experience allows their multidisciplinary boards to manage complex cases that smaller centers might deem untreatable.
Patient Consensus: Patients note that staging involves the entire disease picture rather than just liver scans. They emphasize that initial unresectability can change, as chemotherapy often shrinks tumors enough to allow for later surgery.